Tax Season is Here! Save 15% on H&R Block Online
iconAll times are GMT -4. The time now is 01:05 PM. | Search:

» StockRants Stock Forum » Public Stock Forums » US Stock Picks » Buy: $CTIC - Cell Therapeutics, Inc.



Reply
 
Thread Tools Search this Thread
Old 05-06-2009, 04:47 PM   Nav to Top  #41
Germs
VIP Trader
 
Germs's Avatar
 
Join Date: Apr 2009
Location: Bellflower
Posts: 59
Favorites: LVS, CTIC, CBAI
Rep Power: 164
Reputation: 851
Germs is a splendid one to beholdGerms is a splendid one to beholdGerms is a splendid one to beholdGerms is a splendid one to beholdGerms is a splendid one to beholdGerms is a splendid one to beholdGerms is a splendid one to behold
Thread Starter
Default

Nice run fo CTIC today. Congrats to all who made some $$$. The train is still taking passangers on board. Even if it goes down tomorrow after the first quarter financial report, CTIC will have a jump later on. Just hang in there. Hold and be patience. Sooner or later, we will continue making money. Just remember NASDAQ estimated target price of $50.00 for 2009 and the approval by FDA of Pixantrone and later Opaxio.
Today we felt that we kind of reaching the moon, but wait until we get to mars, jupiter, pluto, etc. This is that the beginning. Best of luck to everyone. Germs
Germs is offline   1 thumbs up / 0 thumbs down. Rate this post Yes | No Reply With Quote
Old 05-06-2009, 04:47 PM   Nav to Top  #42
JonW
Rocket Man
 
JonW's Avatar
 
Join Date: Apr 2009
Location: London
Posts: 345
Favorites: PNA.AX, AFR.L, CTIC, XKEMQ
Rep Power: 306
Reputation: 4127
JonW has a reputation beyond reputeJonW has a reputation beyond reputeJonW has a reputation beyond reputeJonW has a reputation beyond reputeJonW has a reputation beyond reputeJonW has a reputation beyond reputeJonW has a reputation beyond reputeJonW has a reputation beyond reputeJonW has a reputation beyond reputeJonW has a reputation beyond reputeJonW has a reputation beyond repute
Default Count me in for Vegas

The Vegas trip sounds good - if CTIC gets to 12 bucks, a few of us should charter a plane from the UK Hopefully we won't lose all the money in Vegas before we come back!!



Kerching!!

JonW
__________________
"Everything happens for a reason. There is no such thing as coincidence. Listen lots and talk a little and you will eventually figure out the reasons for most things. This should tell you all you need to know about when to buy and when to sell. Always remember, though, that money is just money and true wealth lies in contentment."
JonW is offline   Rate this post Yes | No Reply With Quote
Old 05-06-2009, 04:58 PM   Nav to Top  #43
Germs
VIP Trader
 
Germs's Avatar
 
Join Date: Apr 2009
Location: Bellflower
Posts: 59
Favorites: LVS, CTIC, CBAI
Rep Power: 164
Reputation: 851
Germs is a splendid one to beholdGerms is a splendid one to beholdGerms is a splendid one to beholdGerms is a splendid one to beholdGerms is a splendid one to beholdGerms is a splendid one to beholdGerms is a splendid one to behold
Thread Starter
Default

I love Las Vegas. I usually go 3-4 time/yr. I will love to gumble in LVS and MGM and chat with all of you about our trading experiences, while having a lap dance . Sawri will be delited also, since he owns so many shares of LVS. lol. That will be our trade mark. Las Vegas lap dances.
Germs is offline   Rate this post Yes | No Reply With Quote
Old 05-06-2009, 05:10 PM   Nav to Top  #44
ghoshdd
VIP Trader
 
ghoshdd's Avatar
 
Join Date: Apr 2009
Location: New Jersey
Posts: 20
Rep Power: 150
Reputation: 559
ghoshdd is a name known to allghoshdd is a name known to allghoshdd is a name known to allghoshdd is a name known to allghoshdd is a name known to allghoshdd is a name known to all
Default

Great call Germs..I didn't buy this one. During sometime in January'09 I put a limit order of 0.075 to buy 50000 of CTIC and then cancelled it after few days. But it went down to 0.05 after my order cancellation.
I cancelled my order because someone told me it will do reverse split. It is my bad luck..
ghoshdd is offline   Rate this post Yes | No Reply With Quote
Old 05-06-2009, 05:13 PM   Nav to Top  #45
VicVan
UberTrader
 
VicVan's Avatar
 
Join Date: Apr 2009
Location: London
Posts: 666
Favorites: ANTO, GE, XL
Rep Power: 319
Reputation: 4102
VicVan has a reputation beyond reputeVicVan has a reputation beyond reputeVicVan has a reputation beyond reputeVicVan has a reputation beyond reputeVicVan has a reputation beyond reputeVicVan has a reputation beyond reputeVicVan has a reputation beyond reputeVicVan has a reputation beyond reputeVicVan has a reputation beyond reputeVicVan has a reputation beyond reputeVicVan has a reputation beyond repute
Default

Tut tut no lap dances for you this year

Before the planned conference I think we have to play an online poker game. Stock rants poker club - do it, do it, do it

Oh..... forgot the dumb US laws that prevent online gambling! guess we have to play for kudos (until we get to vegas!)

Reading through a ton of stocks - all pretty dull at the moment. Plant Health Inc looks good for future. Red32 - online casino (funnily enough) profits ok but just not yet.... many are "just not yet" so bored
__________________
Always do your own research and make up your own mind on any stock. Top investors follow themselves, sheep get slaughtered. Any tip, suggestion or comment posted by me is simply a suggestion / prompt for you to make up your own mind. No liability will be accepted. Its not a professional view, its a suggestion. Shares go up and down. Always spread your investments, always set your stops both up and down. If shorting or Futures investing, know what your doing. You cant beat the sharks, but you can swim on their back. Trade lucky.
VicVan is offline   Rate this post Yes | No Reply With Quote
Old 05-06-2009, 06:20 PM   Nav to Top  #46
Navid
UberTrader
 
Navid's Avatar
 
Join Date: Apr 2009
Location: Washington
Posts: 69
Favorites: LVS FAS SKF
Rep Power: 177
Reputation: 1182
Navid has much to be proud ofNavid has much to be proud ofNavid has much to be proud ofNavid has much to be proud ofNavid has much to be proud ofNavid has much to be proud ofNavid has much to be proud ofNavid has much to be proud ofNavid has much to be proud of
Default

CTIC is up to 1.60 (25% more in AH)...VNDA shot up 600% after it got FDA approved. What's the best play on CTIC now for those that missed out?

For those that have followed CTIC, what's your take on price movement? Will there be a retracement after such a big jump? I'd hate to chase this stock if it's just a pump right now, and will wait till it settles down after this euphoria calms.
Navid is offline   Rate this post Yes | No Reply With Quote
Old 05-06-2009, 09:55 PM   Nav to Top  #47
terson
VIP Trader
 
terson's Avatar
 
Join Date: Apr 2009
Location: Richmond
Posts: 59
Favorites: LVS CPRK
Rep Power: 166
Reputation: 903
terson is a splendid one to beholdterson is a splendid one to beholdterson is a splendid one to beholdterson is a splendid one to beholdterson is a splendid one to beholdterson is a splendid one to beholdterson is a splendid one to beholdterson is a splendid one to behold
Default

Anyone know if they have filed the app with FDA?
terson is offline   Rate this post Yes | No Reply With Quote
Old 05-07-2009, 12:17 AM   Nav to Top  #48
chumptochamp
UberTrader
 
chumptochamp's Avatar
 
Join Date: Apr 2009
Location: winnipeg
Posts: 76
Favorites: cbl,api, bry
Rep Power: 223
Reputation: 2317
chumptochamp has a reputation beyond reputechumptochamp has a reputation beyond reputechumptochamp has a reputation beyond reputechumptochamp has a reputation beyond reputechumptochamp has a reputation beyond reputechumptochamp has a reputation beyond reputechumptochamp has a reputation beyond reputechumptochamp has a reputation beyond reputechumptochamp has a reputation beyond reputechumptochamp has a reputation beyond reputechumptochamp has a reputation beyond repute
Default fda application

I believe they are calling it a rolling FDA submission. In other words, it takes about 1000emails and faxs before the FDA are finally satisfied with the submission. This process can take months literally, and that is just to get the submission accepted. They may be able t expediate things as this is a cancer medication and is time critical but the fact remains there will be a number of long months ahead that the company has to keep coming up with news to keep themselves in the investors minds and hearts.

By the way I have a few questions if anybody is contacting IR at Ctic in the future. Who is doing their production for sales in Europe? According to their new report they are allowed to use pixantrone if failure to gold standards occurs. Alright,thats great news as failure can be in the 60 -70% range for aggressive non hodgkins. Where are they producing the drug? What is the cost of the product per treatment? Which countries are involved? Europe is big! I was under the assumption that each country negotiates a price for their product, like it is here in North America. That is why alot of Canadian prices are vastly different then American med prices. Who is doing the marketing for the company in Europe, they certainly do not have a sales force in place. No personal face to face with the docs, no sales of drugs. We physcians are pretty obtuse unless it stares us in the face.

Bottom line that European statement was great for movement of the stock but has no real teeth. There are way too many questions unanswered. I really feel that the company will run out of promotional items before the summer and the price will come back. I am now playing the waiting game. LOL
chumptochamp is offline   3 thumbs up / 0 thumbs down. Rate this post Yes | No Reply With Quote
Old 05-07-2009, 02:08 AM   Nav to Top  #49
Scott68
UberTrader
 
Scott68's Avatar
 
Join Date: Apr 2009
Location: South Bend, Washington
Posts: 110
Favorites: LVS CTIC BGM
Rep Power: 279
Reputation: 3679
Scott68 has a reputation beyond reputeScott68 has a reputation beyond reputeScott68 has a reputation beyond reputeScott68 has a reputation beyond reputeScott68 has a reputation beyond reputeScott68 has a reputation beyond reputeScott68 has a reputation beyond reputeScott68 has a reputation beyond reputeScott68 has a reputation beyond reputeScott68 has a reputation beyond reputeScott68 has a reputation beyond repute
Default GREAT Earnings Report

Here's the link ... should be interesting on Thursday:

Cell Therapeutics Reports 76% Decrease in First Quarter 2009 Net Loss Attributable to Common Shareholders; Completion of Pixantrone NDA Submission on Track for Second Quarter 2009 - Yahoo! Finance
__________________
Taking investment advice from me probably isn't wise. I'm an amateur. You've been warned.
Scott68 is offline   Rate this post Yes | No Reply With Quote
Old 05-07-2009, 02:53 AM   Nav to Top  #50
Germs
VIP Trader
 
Germs's Avatar
 
Join Date: Apr 2009
Location: Bellflower
Posts: 59
Favorites: LVS, CTIC, CBAI
Rep Power: 164
Reputation: 851
Germs is a splendid one to beholdGerms is a splendid one to beholdGerms is a splendid one to beholdGerms is a splendid one to beholdGerms is a splendid one to beholdGerms is a splendid one to beholdGerms is a splendid one to behold
Thread Starter
Default CTIC is doing well

CTIC is doing well.

Pixantrone Named-Patient Program Initiated in Europe

SEATTLE, May 7 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) reported recent accomplishments and financial results for the quarter ended March 31, 2009.

"Our focus for the first half of 2009 was to initiate and complete the NDA submission for pixantrone while we implemented final steps in our cost cutting efforts and raised much needed operating capital on the least dilutive terms possible -- all while cleaning up the Company's capital structure," said James A. Bianco, M.D., CEO of CTI. "We are pleased with our results as reflected in our first quarter financials. We have cut our net operating losses attributable to common shareholders by 76%, raised gross proceeds of $44.3 million in 2009 and eliminated all of our outstanding preferred stock, while staying on track to complete the NDA submission for pixantrone in June 2009."

Recent Highlights
-- Initiated a rolling submission of a New Drug Application (NDA) to the
U.S. Food and Drug Administration (FDA) for pixantrone and are
targeting completing this NDA submission in June 2009, which if
granted priority review could lead to an FDA approval decision as
early as December 2009.
-- Pixantrone Phase III study results to be presented at the American
Society of Clinical Oncology Conference on June 1, 2009.
-- Pixantrone is now available through a named-patient program in Europe.
-- Raised $23.8 million through the sale of Series 1 Preferred Stock to a
single institutional investor and upon the exercise of the associated
common stock warrants. The investor subsequently converted 100% of the
Series 1 Preferred Stock to common stock. CTI has no remaining issued
or outstanding preferred stock.

-- Received $20.5 million in gross proceeds in 2009 from Spectrum
Pharmaceuticals, Inc. associated with the initial divestiture of
Zevalin to the joint venture with Spectrum and the subsequent sale of
CTI's remaining interest in this joint venture (total $28.0 million
received to date with up to an additional $3.5 million owed).

Total net operating expenses decreased $21.8 million, or 77%, to $6.6 million for the quarter ended March 31, 2009 compared to $28.4 million for the same period in 2008 as a result of a $10.2 million one-time gain on the sale CTI's investment in the Zevalin joint venture coupled with a decrease in research and development expenses. Excluding the one-time gain, total net operating expenses decreased 41% over the same period last year. Research and development expenses decreased 7.9 million, or 50%, to $8.0 million for the current quarter compared to $15.9 million for the same period in 2008 as the result of cost reduction initiatives and expenses related to our clinical trial programs. Net loss attributable to common shareholders decreased $41.5 million, or 76%, to $13.1 million ($0.05 per share) for the quarter ended March 31, 2009, compared to $54.6 million ($7.68 per share) for the comparable period in 2008. The reduction in net loss per share is primarily due to an increase in the number of shares outstanding, reduction of expenses and gain on sale of CTI's investment in the Zevalin joint venture.

CTI had approximately $0.7 million in cash and cash equivalents, securities available-for-sale, and interest receivable as of March 31, 2009. In addition, on April 3, 2009, CTI received $6.5 million in gross proceeds from Spectrum associated with the sale of its interest in the Zevalin joint venture and expects to receive up to an additional $3.5 million upon the completion of Spectrum's payment obligations to CTI. In April 2009 CTI received $20.0 million in gross proceeds upon the sale of its Series 1 Preferred Stock and an additional $3.8 million upon the exercise of the associated common stock warrants in May 2009.

Three Months Ended
March 31,
---------
2009 2008
---- ----
Revenues:
Product sales $- $3,374
License and contract revenue 20 20
-- --
Total revenues 20 3,394
-- -----
Operating expenses, net:
Cost of product sold - 890
Research and development 7,956 15,855
Selling, general and administrative 8,874 11,210
Amortization of purchased intangibles - 397
Gain on sale of Zevalin (10,244) -
------- ---
Total operating expenses, net 6,586 28,352
----- ------
Loss from operations (6,566) (24,958)
Other income (expense):
Investment and other income, net 34 260
Interest expense (1,617) (1,985)
Amortization of debt discount and
issuance costs (4,851) (10,944)
Foreign exchange gain (loss) 41 (2,237)
Make-whole interest expense (6,345) (7,781)
Gain on derivative liabilities, net 5,622 11,744
Loss on exchange of convertible notes - (2,295)
Equity loss from investment in
joint venture (1,204) -
Settlement expense (170) -
---- ---
Net loss before
noncontrolling
interest (15,056) (38,196)
Noncontrolling interest 89 32
-- --
Net loss attributable to CTI (14,967) (38,164)
Gain on restructuring of
preferred stock 2,116 -
Preferred stock dividends (23) (242)
Deemed dividends on conversion
of preferred stock (250) (16,198)
---- -------
Net loss attributable
to CTI common shareholders $(13,124) $(54,604)
======== ========
Basic and diluted net loss
per common share $(0.05) $(7.68)
====== ======
Shares used in calculation
of basic and diluted
net loss per common share (1) 285,525 7,107
======= =====


Balance Sheet Data: (amounts in thousands)

March 31, December 31,
2009 2008
---- ----
(unaudited)
Cash and cash equivalents
and securities available-for-sale $748 $10,671
Restricted cash - 6,640
Working capital (22,776) (14,141)
Total assets 42,933 64,243
Convertible debt 119,030 142,373
Accumulated deficit (1,325,444) (1,312,320)
Total deficit (115,984) (132,061)

(1) Amounts reflect a one-for-ten reverse stock split of our
common stock effective August 31, 2008.


SOURCE Cell Therapeutics, Inc.
Germs is offline   1 thumbs up / 0 thumbs down. Rate this post Yes | No Reply With Quote
Reply

Tags
CTIC, Pixantrone

Similar Threads
Thread Thread Starter Forum Replies Last Post
Spectrum Pharmaceuticals Wins Arbitration with Cell Therapeutics, Inc aim2high Rumors & News 0 05-26-2009 07:17 AM
CTIC Hdilla Traders Lounge 4 05-15-2009 01:01 PM
Watch: CTIC, Cell Therapeutics Inc (Nasdaq/ Healthcare) rfaust09 US Stock Picks 8 05-06-2009 10:14 PM


Thread Tools Search this Thread
Search this Thread:

Advanced Search

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On